Group One Trading’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $98.1M | Sell |
6,649,300
-2,005,800
| -23% | -$13.8M | 0.14% | 135 |
|
|
2026
Q1 | $36.6M | Sell |
8,655,100
-2,551,500
| -23% | -$11.4M | 0.07% | 270 |
|
|
2025
Q4 | $42.2M | Buy |
11,206,600
+1,692,000
| +18% | +$3.29M | 0.07% | 250 |
|
|
2025
Q3 | $15.3M | Buy |
9,514,600
+5,506,600
| +137% | +$9.81M | 0.03% | 641 |
|
|
2025
Q2 | $8.78M | Buy |
4,008,000
+1,938,100
| +94% | +$2.97M | 0.02% | 905 |
|
|
2025
Q1 | $2.24M | Sell |
2,069,900
-174,300
| -8% | -$207K | 0.01% | 1725 |
|
|
2024
Q4 | $2.33M | Buy |
2,244,200
+367,400
| +20% | +$419K | 0.01% | 1784 |
|
|
2024
Q3 | $2.35M | Sell |
1,876,800
-661,500
| -26% | -$808K | 0.01% | 1602 |
|
|
2024
Q2 | $3.02M | Buy |
2,538,300
+1,816,200
| +252% | +$2.47M | 0.01% | 1134 |
|
|
2024
Q1 | $729K | Buy |
722,100
+630,200
| +686% | +$529K | ﹤0.01% | 2374 |
|
|
2023
Q4 | $97.4K | Sell |
91,900
-202,400
| -69% | -$219K | ﹤0.01% | 4492 |
|
|
2023
Q3 | $483K | Buy |
294,300
+139,300
| +90% | +$220K | ﹤0.01% | 2945 |
|
|
2023
Q2 | $243K | Sell |
155,000
-50,900
| -25% | -$81.8K | ﹤0.01% | 3738 |
|
|
2023
Q1 | $294K | Buy |
205,900
+85,200
| +71% | +$211K | ﹤0.01% | 3302 |
|
|
2022
Q4 | $285K | Buy |
120,700
+8,800
| +8% | +$24.7K | ﹤0.01% | 3539 |
|
|
2022
Q3 | $226K | Sell |
111,900
-4,100
| -4% | -$11.3K | ﹤0.01% | 4019 |
|
|
2022
Q2 | $259K | Buy |
116,000
+37,600
| +48% | +$110K | ﹤0.01% | 4046 |
|
|
2022
Q1 | $524K | Buy |
78,400
+63,100
| +412% | +$369K | ﹤0.01% | 3765 |
|
|
2021
Q4 | $85K | Sell |
15,300
-6,200
| -29% | -$46.9K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $197K | Sell |
21,500
-40,900
| -66% | -$379K | ﹤0.01% | 5189 |
|
|
2021
Q2 | $693K | Buy |
62,400
+49,600
| +388% | +$484K | ﹤0.01% | 3854 |
|
|
2021
Q1 | $109K | Buy |
12,800
+11,900
| +1,322% | +$97.4K | ﹤0.01% | 5580 |
|
|
2020
Q4 | $5K | Buy |
+900
| New | +$3.6K | ﹤0.01% | 6036 |
|
|
2019
Q1 | – | Sell |
-1,154
| Closed | -$71K | – | 5322 |
|
|
2018
Q4 | $71K | Hold |
1,154
| – | – | ﹤0.01% | 3373 |
|
|
2018
Q3 | $70K | Hold |
1,154
| – | – | ﹤0.01% | 3769 |
|
|
2018
Q2 | $197K | Buy |
1,154
+116
| +11% | +$31.8K | ﹤0.01% | 3062 |
|
|
2018
Q1 | $179K | Buy |
1,038
+443
| +74% | +$126K | ﹤0.01% | 2871 |
|
|
2017
Q4 | $234K | Hold |
595
| – | – | ﹤0.01% | 2824 |
|
|
2017
Q3 | $315K | Buy |
595
+2
| +0.3% | +$1.32K | ﹤0.01% | 2426 |
|
|
2017
Q2 | $517K | Sell |
593
-8
| -1% | -$6.96K | 0.01% | 1945 |
|
|
2017
Q1 | $550K | Sell |
601
-1,870
| -76% | -$3.1M | 0.01% | 1789 |
|
|
2016
Q4 | $7.19M | Buy |
+2,471
| New | +$14.4M | 0.07% | 311 |
|
Other funds holding SLS
AFM
Group One Trading's SLS Position: Q1 2024 in Review
Group One Trading sold out of SELLAS Life Sciences (SLS) in Q1 2024, closing a stake of 186,355 shares — an estimated $157K sold.
Group One Trading first reported a position in SLS in Q4 2016 and held it in 17 quarters. The position peaked at $233K in Q1 2021. 30 funds tracked by Wall St. Rank hold SLS as of Q1 2024.
- Group One Trading reported no remaining SELLAS Life Sciences position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 186,355 SELLAS Life Sciences shares in Q1 2024, an estimated $157K.
- Group One Trading first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 17 quarters.
- Group One Trading's SELLAS Life Sciences position peaked at $233K in Q1 2021.
- 30 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.